Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endothelial Lamellar Keratoplasty (ELK) with Tisseel adhesive
2005-002389-13Phase 4Completed
- Sponsor
- Moorfields Eye Hospital
- Start
- Oct 2005
- Modality
- Recombinant Proteins and Enzymes, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tisseel in corneal decompensation, Fuchs endothelial dystrophy (FED) and bullous keratopathy (PBK), sponsored by Moorfields Eye Hospital. Primary endpoints: Rate of graft dislocation, Proportion of grafts becoming clear and 6 more. Started Oct 2005; status: completed.
02
Drugs
tisseel
03
Conditions
corneal decompensationFuchs endothelial dystrophy (FED)bullous keratopathy (PBK)
Beyond the preview
Go deeper on 2005-002389-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002389-13.